Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling? [electronic resource]
Producer: 20121102Description: 859-68 p. digitalISSN:- 1555-7162
- Adult
- Aged
- Aged, 80 and over
- Antidepressive Agents, Second-Generation -- administration & dosage
- Citalopram -- administration & dosage
- Death, Sudden, Cardiac -- etiology
- Drug and Narcotic Control
- Female
- Heart Ventricles -- drug effects
- Humans
- Long QT Syndrome -- chemically induced
- Male
- Middle Aged
- Risk Factors
- Selective Serotonin Reuptake Inhibitors -- administration & dosage
- Torsades de Pointes -- chemically induced
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Case Reports; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.